ESPE2014 Poster Presentations Bone (1) (12 abstracts)
Genetic Study of Osteogenesis Imperfecta: Two Novel Mutations in COL1A1 and COL1A2
Lidia Castro-Feijóo a , Lourdes Loidi b , Nuria Quiroga c , Paloma Cabanas d , Claudia Heredia d , Rosaura Leis e , Francisco Barros b , Manuel Pombo d & Jesús Barreiro d
aUnidad de Endocrinología Pediátrica y Crecimiento, Dpto. de Pediatría, Fundación Ramón Domínguez, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, Santiago de Compostela. A Coruña, Spain; bFundación Pública Galega de Medicina Xenómica, Santiago de Compostela, A Coruña, Spain, cDpto de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain; dUnidad de Endocrinología Pediátrica y Crecimiento, Dpto de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain; eUnidad de Investigación en Nutrición y Desarrollo Humano de Galicia, Dpto de Pediatría, Hospital clínico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
Background: Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous rare disorder characterized by variable symptoms including predisposition to fractures. OI has been associated with mutations affecting the synthesis of type I collagen. However, the new technologies have permitted the identification of other responsible genes which are in the collagen metabolic pathway, while others are not.
Objective: Characterize the genotype of patients with OI.
Methods: Study by Next Generation Sequencing (5500XL SOLID) the OI related genes: COL1A1, COL1A2, CRTAP, FKBP10, LEPRE1, PPIB, SERPINF1, SERPINH1 and SP7 and confirmation of the identified mutations by PCR and Sanger sequencing.
Results and discussion: Patient 1 (male with severe phenotype of OI). Heterozygous carrier of the COL1A2 mutation NM_000089.3: c.1207G >T (p.Gly403Cys). This mutation has not been previously described. The theoretical predictors suggest pathogenicity, which is consistent with the clear phenotype of OI in this patient. Patient 2 (girl with mild phenotype of OI). Heterozygous carrier of the COL1A1 mutation NM_000088.3: c.572G > C (p.Gly191Ala). This mutation appears in The Human Gene Mutation Database associated with cervical artery dissection and the missense predictions indicate pathogenicity. Patients 3 and 4 (siblings with moderate phenotype of OI). Both girls are heterozygous carriers of the COL1A1 mutation NM_000088.3: c.2T > C (p.Met1?). This mutation has not been previously described and there is not data of associated phenotype. This variation affects the translation initiation codon of the mRNA which indicates pathogenicity.
Conclusion: The genetic analysis confirmed the diagnosis of OI in all the patients studied. These results allowed a better classification of patients and permitted an adequate genetic counselling. One COL1A1 and one COL1A2 novel mutations are described.
Article tools
My recent searches
My recently viewed abstracts
Authors
ESPE Abstracts
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more